Table 2 Multivariate analyses of progression-free and overall survival in 53 patients with ECOG PS 0-1
From: Combinatory effect of BRCA1 and HERC2 expression on outcome in advanced non-small-cell lung cancer
Progression-free survival | |||
Hazard ratio | 95 % CI | P-value | |
Performance status | |||
0 | 1.00 (referent) | ||
1 | 1.45 | 0.62-3.41 | 0.39 |
BRCA1/HERC2 expression | |||
Low/Low | 1 (referent) | ||
Other combinations | 1.45 | 1.10-4.73 | 0.03 |
Overall survival | |||
Hazard ratio | 95 % CI | P-value | |
Performance status | |||
0 | 1 (referent) | ||
1 | 1.35 | 0.45-4.1 | 0.58 |
BRCA1/HERC2 expression | |||
Low/Low | 1 (referent) | ||
Other combinations | 3.70 | 1.54 -9.10 | 0.004 |